- Stories /
- Healthcare /
- SaniSure /


Created one of the largest independent single-use solutions platforms in the bioprocessing industry through innovation and buy-and-build

2019 – Current
Good to great
c.50%
Sales CAGR 2020-2022Launching innovative, proprietary solutions serving high-value customer needs in critical process steps
Five
acquisitions completed in the first 12 monthsCompleted five acquisitions in first 12 months to form the global platform, accelerating each acquired business’ international growth
1,000+
pharmaceutical, CDMO and biotech customersIncreasing portfolio exposure to the high-growth biologics and cell and gene therapy markets
Investing to support commercial and operational excellence initiatives to better serve our customers